Table 1 Clinical characteristics of the subjects
All subjects | HT patients 1 | HT patients 2 | WhHT patients 1 | WhHT patients 2 | |
|---|---|---|---|---|---|
N (male/female) | 105 (62/43) | 22 (15/7) | 22 (15/7) | 22 (10/12) | 22 (10/12) |
Age, years | 48.3 ± 13.2 | 47.9 ± 13.5 | 48.2 ± 13.5 | 45 ± 13.2 | 46 ± 13.2 |
Diabetes [n (%)] | 8 (7.6) | 0 | 0 | 0 | 0 |
CV disease [n (%)] | 3 (3.8) | 0 | 0 | 0 | 0 |
Current smoker [n (%)] | 19 (18.1) | 5 (22.7) | 5 (22.7) | 4 (18.2) | 4 (18.2) |
BMI (kg/m2) | 27.4 ± 3.9 | 27.3 ± 4.5 | 26.6 ± 4.3 | 26.4 ± 4.2 | 26.6 ± 4.5 |
Blood glucose (mmol/l) | 5.3 ± 0.5 | 5.9 ± 1.7 | 5.7 ± 1.3 | 5.3 ± 0.6 | 5.3 ± 0.5 |
GFR-EPI (ml/min/1.73 m2) | 100.1 ± 14 | 98.2 ± 14.9 | 98.2 ± 14.9 | 118 ± 18.4 | 98 ± 16.5 |
Uric acid (µmol/l) | 344.3 ± 96.3 | 316.8 ± 93.1 | 315 ± 93 | 313 ± 74 | 312 ± 79.4 |
Total cholesterol (mmol/l) | 5.7 ± 1.1 | 6.1 ± 1.1 | 5.8 ± 1.2 | 5.6 ± 1.7 | 5.4 ± 1.1 |
LDL (mmol/l) | 3.6 ± 0.9 | 3.9 ± 1.0 | 3.7 ± 1.1 | 3.6 ± 1.5 | 3.5 ± 0.9 |
HDL (mmol/l) | 1.1 ± 0.4 | 1.5 ± 0.4 | 1.4 ± 0.4 | 1.5 ± 0.4 | 1.4 ± 0.3 |
Triglyceride (mmol/l) | 1.6 ± 0.6 | 1.7 ± 1.3 | 1.6 ± 0.9 | 1.5 ± 1 | 1.2 ± 0.6 |